Type
Internal restructuring
Country
World
Region
Location of affected unit(s)
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

4,000 jobs
Number of planned job losses
Job loss
Announcement Date
4 February 2010
Employment effect (start)
Foreseen end date

Description

Glaxo Smith Kline, a British multinational company that operates in the pharmaceutical sector, is to cut 4,000 jobs worldwide. The job-cuts will affect research units in Italy, United Kingdom, Croatia, Poland and Canada. The company announced a cost-saving plan that envisages the closure of its research units engaged in neuroscience research. As of February 2010, there is no confirmed information about the timeline but the measure will probably be implemented in the second half of 2010. Glaxo has around 103,000 employees worldwide.


Sources

  • 5 February 2010: La Repubblica
  • 5 February 2010: Il corriere della sera
  • 5 February 2010: Reuters

Citation

Eurofound (2010), Glaxo Smith Kline, Internal restructuring in World, factsheet number 70147, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/70147.